Researchers at the Technical University of Munich (TUM) have developed a system that helps patients learn to move their ...
Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...
Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord InjuryMARLBOROUGH, Mass. and YOKNEAM ...
FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7. The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord injury ...
The FDA clearance marks a significant milestone for Lifeward, reinforcing its leadership in the medical exoskeleton market. With prior regulatory and reimbursement wins, the launch of ReWalk 7 ...
The IX Back Volton is a lightweight, battery-powered exoskeleton designed to reduce physical strain for workers in demanding ...
The Company made history in 2014 when it received the nation’s first FDA clearance for an exoskeleton medical device for individuals with SCI. Lifeward will begin sales of the ReWalk 7 in the ...
LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.